These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30790285)

  • 1. Identification of 8-miRNAs as biomarkers for nonalcoholic fatty liver disease.
    Yu Y; Zhu J; Liu J; Huang M; Wan JX
    J Cell Physiol; 2019 Aug; 234(10):17361-17369. PubMed ID: 30790285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD.
    Zhu M; Wang Q; Zhou W; Liu T; Yang L; Zheng P; Zhang L; Ji G
    Sci Rep; 2018 May; 8(1):7628. PubMed ID: 29769539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of eight meta-signature miRNAs as potential biomarkers for oropharyngeal cancers.
    Li B; Kyung HM
    Cancer Genet; 2019 Apr; 233-234():75-83. PubMed ID: 30578154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of six key miRNAs associated with breast cancer through screening large-scale microarray data.
    Liang F; Yang M; Tong N; Fang J; Pan Y; Li J; Zhang X
    Oncol Lett; 2018 Oct; 16(4):4159-4168. PubMed ID: 30250531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microRNAs related to myocardial ischemic reperfusion injury.
    Liu K; Ma L; Zhou F; Yang Y; Hu HB; Wang L; Zhong L
    J Cell Physiol; 2019 Jul; 234(7):11380-11390. PubMed ID: 30552681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
    Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
    Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
    Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
    J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.
    Chen Y; Huang H; Xu C; Yu C; Li Y
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28275212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
    Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.
    Soronen J; Yki-Järvinen H; Zhou Y; Sädevirta S; Sarin AP; Leivonen M; Sevastianova K; Perttilä J; Laurila PP; Sigruener A; Schmitz G; Olkkonen VM
    Physiol Rep; 2016 Jan; 4(1):. PubMed ID: 26733244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Huang S; Sun C; Hou Y; Tang Y; Zhu Z; Zhang Z; Zhang Y; Wang L; Zhao Q; Chen MG; Guo Z; Wang D; Ju W; Zhou Q; Wu L; He X
    Sci Rep; 2018 May; 8(1):7630. PubMed ID: 29769552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.
    Zhang YJ; Hu Y; Li J; Chi YJ; Jiang WW; Zhang F; Liu YL
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):65-79. PubMed ID: 28119261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non‑alcoholic fatty liver disease.
    Wu H; Song X; Ling Y; Zhou J; Tao Z; Shen Y
    Mol Med Rep; 2019 Apr; 19(4):2649-2659. PubMed ID: 30720100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling.
    Hsu SD; Huang HY; Chou CH; Sun YM; Hsu MT; Tsou AP
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S12. PubMed ID: 25707768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics Analysis of Key Differentially Expressed Genes in Nonalcoholic Fatty Liver Disease Mice Models.
    Hou C; Feng W; Wei S; Wang Y; Xu X; Wei J; Ma Z; Du Y; Guo J; He Y; Kong F; Tang R; Zheng K
    Gene Expr; 2018 Dec; 19(1):25-35. PubMed ID: 30135001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hsa-mir-34a, hsa-mir-124, and hsa-mir-204 as signatures for cataract.
    Wei YL; Sun H
    J Cell Physiol; 2019 Jul; 234(7):10709-10717. PubMed ID: 30478927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.